The U.S. Food and Drug Administration (FDA) approved the first blood test that looks for the antibodies against the novel coronavirus that causes COVID-19. This is different than assays that test for presence of the virus—those test to determine if a patient has COVID-19. These new antibody tests determine if the person was exposed to the virus, had COVID-19 and recovered. And it suggests, if positive, that the person is now immune to COVID-19 and can’t get it again.

Research Triangle Park, North Carolina-based Cellex was granted an emergency use authorization (EUA) on its test yesterday.

The test is performed on a blood sample taken from a patient’s vein and can be performed by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), the Health and Human Services division that oversees clinical diagnostic testing in the United States.

HOUSTON — A University of Houston professor is waiting for FDA approval of a waterproofing solution that he says can shield personal protective equipment such as N95 masks from the droplets that spread COVID-19.

Professor Seamus Curran said he developed the hydrophobic coating in 2011 while testing it on fabrics. He continued creating similar solutions to be used on wood and masonry with his company, Integricote.

When COVID-19 broke out, he felt the coating could help, especially as health care workers warned of a nationwide shortage of personal protective equipment (PPE) such as N95 masks that health care workers wear.

At a time when the world is scrambling to find a cure, a vaccine or some sort of viable treatment for the Novel Coronavirus that is rocking the globe, the Ethiopian Ministry of Health (MoH) and the Ministry of Innovation and Technology (MoIT) have disclosed that they have an effective treatment in the pipeline that enhances natural immunity in the fight againt the virus.

Although the details of the ingredients as well as the laboratory procedure and testing were not presented in detail, the two ministries said that a treatment drug has been discovered from the traditional medicines in the country.

The statement that the MoIT issued on March 27, 2020, indicated that the medicine has passed the basic research procedures and was successful in the laboratory modeling processes.

Exclusive: Public Health England document seen by Guardian says four in five ‘expected’ to contract virus.

Li Wenliang, the doctor in China who raised early awareness of the new coronavirus, died of the virus in February at 34. His death was shocking not only because of his role in publicizing the developing epidemic but also — given that young people do not have a high risk of dying from Covid-19 — because of his age.

Is it possible that Dr. Li died because as a doctor who spent a lot of time around severely ill Covid-19 patients, he was infected with such a high dose? After all, though he was one of the first young health care workers to die after being exposed up close and frequently to the virus, he was unfortunately not the last.

The importance of viral dose is being overlooked in discussions of the coronavirus. As with any other poison, viruses are usually more dangerous in larger amounts. Small initial exposures tend to lead to mild or asymptomatic infections, while larger doses can be lethal.

In a joint press statement, the Ministry of Health (MoH) and the Ministry of Innovation and Technology (MoIT) said: “a domestic treatment drug” is being developed by the traditional medicine experts of the country.

The two ministries said the drug was prepared by integrating indigenous traditional medical knowledge with modern science.

The Country says it is developing a cure for Covid-19.